Unclaimed Scholar Profile
Are you George M. Warimwe? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at Kenya Medical Research InstituteASIDASID-7403-0321-4369 orcid.org/0000-0002-4911-6333
George M. Warimwe
Kenya Medical Research Institute•Kenya
Faculty researcher at Kenya Medical Research Institute (KE), specializing in Health & Medical Sciences. [Discipline: Health & Medical Sciences] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: East Africa]
#SARS-CoV-2 and COVID-19 Research#Mosquito-borne diseases and control#Viral Infections and Vectors#COVID-19 epidemiological studies
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 9,512 | 4,566 |
| h-index | 35 | 26 |
| i10-index | 67 | 47 |
Annual Citation Growth
Verified Citations / Year0
2020457
2021+40%639
2022+29%822
2023+33%1.1k
2024-8%1.0k
2025-45%548
2026Scholarship Distribution & Proportions125 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (7,800) • 18% Global Research Impact (1,712)
125 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (125)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
DOI: 10.1016/s0140-6736(20)32661-1 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
Published in Science•2020
DOI: 10.1126/science.abe1916 Verified Peer-Reviewed
Targets of antibodies against Plasmodium falciparum–infected erythrocytes in malaria immunity
Published in Journal of Clinical Investigation•2012
DOI: 10.1172/jci62182 Verified Peer-Reviewed
Rift Valley fever: biology and epidemiology
Published in Journal of General Virology•2019
DOI: 10.1099/jgv.0.001296 Verified Peer-Reviewed
Showing 1 – 5 of 125 publications
1 / 25